A Phase II Study Evaluating Fostamatinib for Hospitalized Adults with COVID-19.

$759,649ZIAFY2020HLNIH

National Heart, Lung, And Blood Institute

Investigators

Richard Childscontact

Linked publications, trials & patents

Paper 34467402 Paper 34268520 Paper 33972701 Paper 33686249 Paper 32034075

View original record on NIH RePORTER →